Know a great AI tool or AI news source? Submit it to AiByts
Nature3 min read

Moderna mRNA vaccine almost halves the risk of skin cancer returning

Long-awaited results from phase III trial show a huge benefit in treating treatment-resistant melanoma.

By Mohana BasuNature AI
Moderna mRNA vaccine almost halves the risk of skin cancer returning

Read the full story

Originally published by Nature AI on Oct 23, 2026.

Read on Nature AI(opens in a new tab)

Comments

Sign in to join the discussion.

No comments yet — be the first to share your thoughts.